HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Daniela Göppner Selected Research
Daniela Göppner Research Topics
Disease
13
Melanoma (Melanoma, Malignant)
11/2023 - 01/2011
6
Neoplasms (Cancer)
01/2016 - 07/2010
3
Neoplasm Metastasis (Metastasis)
11/2023 - 04/2015
3
Skin Neoplasms (Skin Cancer)
01/2017 - 01/2016
1
Cytokine Release Syndrome
10/2021
1
Exanthema (Rash)
01/2021
1
Bullous Pemphigoid (Pemphigoid)
01/2020
1
Disease Progression
01/2016
1
Hepatocellular Carcinoma (Hepatoma)
04/2015
1
Cholangitis
04/2015
1
Atopic Dermatitis (Atopic Eczema)
03/2013
1
Basal Cell Carcinoma (Rodent Ulcer)
01/2011
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2010
1
Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
07/2010
Drug/Important Bio-Agent (IBA)
3
Vemurafenib
IBA
11/2023 - 09/2014
3
pembrolizumab
IBA
10/2021 - 01/2016
3
Ipilimumab
IBA
01/2017 - 01/2013
2
cobimetinib
IBA
11/2023 - 01/2021
2
Immune Checkpoint Inhibitors
IBA
01/2017 - 01/2016
2
Nivolumab
IBA
01/2016 - 01/2016
2
Antibodies
IBA
01/2016 - 01/2016
1
encorafenib
IBA
10/2021
1
binimetinib
IBA
10/2021
1
Creatine Kinase (Creatine Phosphokinase)
IBA
10/2021
1
Transferases
IBA
10/2021
1
Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)
IBA
10/2021
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2021
1
Proteins (Proteins, Gene)
FDA Link
01/2020
1
Autoantibodies
IBA
01/2020
1
Indocyanine Green (Cardio-Green)
FDA Link
Generic
02/2017
1
Monoclonal Antibodies
IBA
01/2017
1
Interferon alpha-2 (Roferon-A)
FDA Link
12/2015
1
Globulins
IBA
03/2013
1
Omalizumab (Xolair)
FDA Link
03/2013
1
Cetuximab (Erbitux)
FDA Link
10/2010
1
denileukin diftitox (Ontak)
FDA Link
07/2010
Therapy/Procedure
9
Therapeutics
11/2023 - 07/2010
2
Aftercare (After-Treatment)
01/2021 - 04/2015
1
Drug Tapering
01/2021
1
Immunotherapy
01/2017
1
Brachytherapy
04/2015
1
Radiofrequency Ablation
04/2015
1
Radioimmunotherapy
07/2010